• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2)、严重急性呼吸综合征冠状病毒 (SARS-CoV) 和中东呼吸综合征冠状病毒 (MERS-CoV) 的发病机制和宿主固有免疫逃避策略的比较综述。

A comparative review of pathogenesis and host innate immunity evasion strategies among the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV).

机构信息

Department of Life Sciences (DLS), School of Environment and Life Sciences (SELS), Independent University, Bangladesh (IUB), Plot 16, Block B, Aftabuddin Ahmed Road, Bashundhara, Dhaka, 1229, Bangladesh.

出版信息

Arch Microbiol. 2021 Jul;203(5):1943-1951. doi: 10.1007/s00203-021-02265-y. Epub 2021 Mar 7.

DOI:10.1007/s00203-021-02265-y
PMID:33682075
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7937358/
Abstract

COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has put the global public health at its highest threat around the world. Previous epidemic caused by the acute respiratory syndrome coronavirus (SARS-CoV) in 2002 is also considered since both the coronaviruses resulted in the similar clinical complications. The outbreak caused by the Middle East respiratory syndrome coronavirus (MERS-CoV) in 2012 had a low rate of disease transmission and death cases. Modes of entry by MERS and SARS coronaviruses are similar to that of SARS-CoV-2, except MERS-CoV utilize different receptor. They all belong to the lineage C of β-coronavirus. Based on the information from the previous reports, the present review is mainly focused on the mechanisms of disease progression by each of these viruses in association to their strategies to escape the host immunity. The viral entry is the first step of pathogenesis associated with attachment of viral spike protein with host receptor help releasing the viral RNA into the host cell. Models of molecular pathogenesis are outlined with virus strategies escaping the host immunity along with the role of various inflammatory cytokines and chemokines in the process. The molecular aspects of pathogenesis have also been discussed.

摘要

由严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)引起的 COVID-19 大流行在全球范围内对全球公共卫生造成了前所未有的威胁。2002 年由急性呼吸系统综合征冠状病毒(SARS-CoV)引起的先前流行也被认为是由于这两种冠状病毒导致了类似的临床并发症。2012 年由中东呼吸系统综合征冠状病毒(MERS-CoV)引起的疫情传播率和死亡病例较低。MERS 和 SARS 冠状病毒的进入模式与 SARS-CoV-2 相似,只是 MERS-CoV 利用不同的受体。它们都属于β冠状病毒的谱系 C。基于以前报告中的信息,本综述主要集中在这些病毒各自引起疾病进展的机制上,以及它们逃避宿主免疫的策略。病毒进入是与病毒刺突蛋白与宿主受体结合从而将病毒 RNA 释放到宿主细胞相关的发病机制的第一步。概述了病毒逃避宿主免疫的策略以及各种炎症细胞因子和趋化因子在该过程中的作用的分子发病机制模型。还讨论了发病机制的分子方面。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/787b/7937358/7c587915e18f/203_2021_2265_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/787b/7937358/37aefc3b24fc/203_2021_2265_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/787b/7937358/65d049891f3a/203_2021_2265_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/787b/7937358/7c587915e18f/203_2021_2265_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/787b/7937358/37aefc3b24fc/203_2021_2265_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/787b/7937358/65d049891f3a/203_2021_2265_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/787b/7937358/7c587915e18f/203_2021_2265_Fig3_HTML.jpg

相似文献

1
A comparative review of pathogenesis and host innate immunity evasion strategies among the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV).严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2)、严重急性呼吸综合征冠状病毒 (SARS-CoV) 和中东呼吸综合征冠状病毒 (MERS-CoV) 的发病机制和宿主固有免疫逃避策略的比较综述。
Arch Microbiol. 2021 Jul;203(5):1943-1951. doi: 10.1007/s00203-021-02265-y. Epub 2021 Mar 7.
2
UBR5 Acts as an Antiviral Host Factor against MERS-CoV via Promoting Ubiquitination and Degradation of ORF4b.UBR5 通过促进 ORF4b 的泛素化和降解来充当抗 MERS-CoV 的抗病毒宿主因子。
J Virol. 2022 Sep 14;96(17):e0074122. doi: 10.1128/jvi.00741-22. Epub 2022 Aug 18.
3
The SARS-Coronavirus Infection Cycle: A Survey of Viral Membrane Proteins, Their Functional Interactions and Pathogenesis.SARS-CoV 感染周期:病毒膜蛋白、功能相互作用及其发病机制概述。
Int J Mol Sci. 2021 Jan 28;22(3):1308. doi: 10.3390/ijms22031308.
4
Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.先天免疫对高致病性冠状病毒和其他重要呼吸道病毒感染的反应。
Front Immunol. 2020 Aug 18;11:1979. doi: 10.3389/fimmu.2020.01979. eCollection 2020.
5
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染:综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
6
Ca Ions Promote Fusion of Middle East Respiratory Syndrome Coronavirus with Host Cells and Increase Infectivity.钙离子促进中东呼吸综合征冠状病毒与宿主细胞融合并增加感染性。
J Virol. 2020 Jun 16;94(13). doi: 10.1128/JVI.00426-20.
7
Middle East Respiratory Syndrome Coronavirus NS4b Protein Inhibits Host RNase L Activation.中东呼吸综合征冠状病毒NS4b蛋白抑制宿主核糖核酸酶L的激活。
mBio. 2016 Mar 29;7(2):e00258. doi: 10.1128/mBio.00258-16.
8
[Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).].[新冠疫情的源头:冠状病毒(β冠状病毒:冠状病毒科)、严重急性呼吸综合征冠状病毒(SARS-CoV)、严重急性呼吸综合征冠状病毒2(SARS-CoV-2,Sarbecovirus亚属)和中东呼吸综合征冠状病毒(MERS-CoV,Merbecovirus亚属)的生态学与遗传学。]
Vopr Virusol. 2020;65(2):62-70. doi: 10.36233/0507-4088-2020-65-2-62-70.
9
Immune responses in COVID-19 and potential vaccines: Lessons learned from SARS and MERS epidemic.COVID-19 的免疫反应和潜在疫苗:从 SARS 和 MERS 疫情中吸取的教训。
Asian Pac J Allergy Immunol. 2020 Mar;38(1):1-9. doi: 10.12932/AP-200220-0772.
10
Modulation of the immune response by Middle East respiratory syndrome coronavirus.中东呼吸综合征冠状病毒对免疫应答的调节。
J Cell Physiol. 2019 Mar;234(3):2143-2151. doi: 10.1002/jcp.27155. Epub 2018 Aug 26.

引用本文的文献

1
SARS-CoV-2 omicron sub-lineages differentially modulate interferon response in human lung epithelial cells.奥密克戎变异株亚谱系在人肺上皮细胞中差异调节干扰素反应。
Virus Res. 2023 Jul 15;332:199134. doi: 10.1016/j.virusres.2023.199134. Epub 2023 May 17.
2
Host Protective Immunity against Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2) and the COVID-19 Vaccine-Induced Immunity against SARS-CoV-2 and Its Variants.宿主对严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的保护性免疫与 COVID-19 疫苗诱导的对 SARS-CoV-2 及其变体的免疫。
Viruses. 2022 Nov 17;14(11):2541. doi: 10.3390/v14112541.
3
How do the severe acute respiratory coronavirus 2 (SARS-CoV-2) and its variants escape the host protective immunity and mediate pathogenesis?

本文引用的文献

1
Antiviral drugs against severe acute respiratory syndrome coronavirus 2 infection triggering the coronavirus disease-19 pandemic.针对严重急性呼吸综合征冠状病毒2感染引发新型冠状病毒肺炎大流行的抗病毒药物。
Tzu Chi Med J. 2020 Aug 25;33(1):7-12. doi: 10.4103/tcmj.tcmj_100_20. eCollection 2021 Jan-Mar.
2
The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections.SARS-CoV、MERS-CoV 和 SARS-CoV-2 冠状病毒感染的比较免疫学特征。
Front Immunol. 2020 Aug 14;11:2033. doi: 10.3389/fimmu.2020.02033. eCollection 2020.
3
Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)及其变种如何逃避宿主的保护性免疫并介导发病机制?
Bull Natl Res Cent. 2022;46(1):255. doi: 10.1186/s42269-022-00945-3. Epub 2022 Oct 12.
4
Overview of dreadful consequences of SARS-CoV-2 invasion in Italy from March 2020 to March 2022.2020年3月至2022年3月期间,意大利新冠病毒入侵的可怕后果概述。
Bull Natl Res Cent. 2022;46(1):176. doi: 10.1186/s42269-022-00867-0. Epub 2022 Jun 20.
5
COVID-19 vaccines: their effectiveness against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its emerging variants.2019冠状病毒病疫苗:它们对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)及其新出现变种的有效性。
Bull Natl Res Cent. 2022;46(1):96. doi: 10.1186/s42269-022-00787-z. Epub 2022 Apr 8.
6
mRNA Vaccines as an Efficient Approach for the Rapid and Robust Induction of Host Immunity Against SARS-CoV-2.mRNA疫苗作为快速有效诱导宿主针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)产生免疫的一种方法。
SN Compr Clin Med. 2022;4(1):88. doi: 10.1007/s42399-022-01168-3. Epub 2022 Apr 1.
7
A review on the induction of host immunity by the current COVID-19 vaccines and a brief non-pharmaceutical intervention to mitigate the pandemic.当前新冠疫苗诱导宿主免疫的综述以及减轻疫情的简要非药物干预措施。
Bull Natl Res Cent. 2022;46(1):31. doi: 10.1186/s42269-022-00719-x. Epub 2022 Feb 16.
8
Evaluation of potential miRNA sponge effects of SARS genomes in human.评估SARS基因组在人类中的潜在微小RNA海绵效应。
Noncoding RNA Res. 2022 Mar;7(1):48-53. doi: 10.1016/j.ncrna.2022.01.003. Epub 2022 Jan 20.
9
The effect of interleukin-6 level at the time of hospitalisation on erectile functions in hospitalised patients with COVID-19.住院时白细胞介素-6 水平对 COVID-19 住院患者勃起功能的影响。
Andrologia. 2022 Feb;54(1):e14285. doi: 10.1111/and.14285. Epub 2021 Oct 22.
10
Innate Immunity in Children and the Role of ACE2 Expression in SARS-CoV-2 Infection.儿童的先天免疫以及ACE2表达在SARS-CoV-2感染中的作用
Pediatr Rep. 2021 Jul 2;13(3):363-382. doi: 10.3390/pediatric13030045.
抗体依赖性增强作用与 SARS-CoV-2 疫苗和疗法。
Nat Microbiol. 2020 Oct;5(10):1185-1191. doi: 10.1038/s41564-020-00789-5. Epub 2020 Sep 9.
4
A brief outline of respiratory viral disease outbreaks: 1889-till date on the public health perspectives.呼吸道病毒病暴发简史:从公共卫生角度看1889年至今
Virusdisease. 2020 Dec;31(4):441-449. doi: 10.1007/s13337-020-00628-5. Epub 2020 Sep 2.
5
Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study.SARS-CoV-2 和 SARS-CoV 的比较嗜性、复制动力学和细胞损伤特征分析及其对 COVID-19 临床表现、传染性和实验室研究的影响:一项观察性研究。
Lancet Microbe. 2020 May;1(1):e14-e23. doi: 10.1016/S2666-5247(20)30004-5. Epub 2020 Apr 21.
6
Increasing host cellular receptor-angiotensin-converting enzyme 2 expression by coronavirus may facilitate 2019-nCoV (or SARS-CoV-2) infection.冠状病毒增加宿主细胞表面受体血管紧张素转化酶 2 的表达可能有助于 2019-nCoV(或 SARS-CoV-2)感染。
J Med Virol. 2020 Nov;92(11):2693-2701. doi: 10.1002/jmv.26139. Epub 2020 Jul 2.
7
The trinity of COVID-19: immunity, inflammation and intervention.COVID-19 的三位一体:免疫、炎症和干预。
Nat Rev Immunol. 2020 Jun;20(6):363-374. doi: 10.1038/s41577-020-0311-8. Epub 2020 Apr 28.
8
SARS-CoV-2, SARS-CoV, and MERS-COV: A comparative overview.严重急性呼吸综合征冠状病毒2、严重急性呼吸综合征冠状病毒和中东呼吸综合征冠状病毒:比较概述。
Infez Med. 2020;28(2):174-184.
9
2019-nCoV (Wuhan virus), a novel Coronavirus: human-to-human transmission, travel-related cases, and vaccine readiness.2019新型冠状病毒(武汉病毒):人际传播、与旅行相关的病例及疫苗研发进展
J Infect Dev Ctries. 2020 Jan 31;14(1):3-17. doi: 10.3855/jidc.12425.
10
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)和 2019 年冠状病毒病(COVID-19):疫情和挑战。
Int J Antimicrob Agents. 2020 Mar;55(3):105924. doi: 10.1016/j.ijantimicag.2020.105924. Epub 2020 Feb 17.